PHARMACY

Salix purchase of Santarus completed

BY Alaric DeArment

RALEIGH, N.C. — Salix Pharmaceuticals has completed its $2.6 billion acquisition of Santarus, Salix said.

The drug maker announced that it had completed the $32-per-share acquisition of Santarus, which the companies announced in November. The combination of the companies’ product portfolios includes 22 marketed products, such as Xifaxan, Glumetza, Zegerid, Relistor and others.

"The acquisition of Santarus is a transformational event for Salix and an important milestone in our growth as the leading gastroenterology-focused specialty pharmaceutical company in the United States," Salix president and CEO Carolyn Logan said. "The creation of a larger, stronger Salix reinforces our premier position in gastroenterology and creates the opportunity for us to expand our digestive disease expertise into other key specialties."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

IMS Health files with SEC for initial public offering

BY Alaric DeArment

DANBURY, Conn. — IMS Health is looking to go public, the healthcare industry research and analytics company said.

IMS, based in Danbury, Conn., said it had filed with the Securities and Exchange Commission for a proposed initial public offering of its common stock, adding that it had not yet determined the number of shares to be offered or the price range of the offering.

The company said it planned to use the net proceeds it received to repay a portion of its long-term debt, and that a registration statement related to the securities had been filed with the SEC, but had not yet become effective.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Rite Aid dispenses prescriptions for health insurance exchange enrollees

BY Alaric DeArment

CAMP HILL, Pa. — Rite Aid is providing prescriptions at no upfront cost to customers who have enrolled in the health insurance marketplaces, but have not received an ID number, the retail pharmacy chain said.

The company said that during the month of January, it would dispense a 15- to 30-day supply of many medications to customers who bring in confirmation of their enrollment until their prescription coverage details are available. The Patient Protection and Affordable Care Act, popularly known as Obamacare, took full effect Wednesday.

"Every pharmacist knows how important it is for people to take their medications as prescribed, without any interruption," Rite Aid EVP pharmacy Robert Thompson said. "Each year, Rite Aid pharmacy teams work with and help guide customers through first-of-the-year insurance plan changes, and that’s especially true this year, as we know that those newly enrolled may have questions or concerns about their prescription coverage."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?